News
-
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE Rights ex-US
Relief Therapeutics completes strategic transition by selling GOLIKE rights outside the U.S. to Nutrisens, focusing on R&D and licensing for commercialized products. Company receives CHF 1.2 million upfront -
COMMUNIQUÉ DE PRESSE
Preliminary results 2024: SBO with strong cash generation and solid results despite challenging market conditions
Schoeller-Bleckmann Oilfield Equipment AG reports strong cash generation and solid results for 2024 despite challenging market conditions. Preliminary results show resilient performance